Abstract:Substance P (SP) is released from sensory nerves in the arteries and heart. It activates neurokinin-1 receptors (NK1Rs) causing vasodilation, immune modulation, and adverse cardiac remodeling. The hypothesis was tested: SP and SP metabolites activate different second messenger signaling pathways. Macrophages, endothelial cells, and fibroblasts metabolized SP to N- and C-terminal metabolites to varying extents. SP 5-11 was the most abundant metabolite followed by SP 1-4, SP 7-11, SP 6-11, SP 3-11, and SP 8-11. In NK1R-expressing human embryonic kidney 293 (HEK293) cells, SP and some C-terminal SP metabolites stimulate the NK1R, promoting the dissociation of several Gα proteins, including Gαs and Gαq from their βγ subunits. SP increases intracellular calcium concentrations ([Ca]i) and cyclic 3',5'-adenosine monophosphate (cAMP) accumulation with similar -log EC50 values of 8.5 ± 0.3 and 7.8 ± 0.1 M, respectively. N-terminal metabolism of SP by up to five amino acids and C-terminal deamidation of SP produce peptides that retain activity to increase [Ca]i but not to increase cAMP. C-terminal metabolism results in the loss of both activities. Thus, [Ca]i and cAMP signaling are differentially affected by SP metabolism. To assess the role of N-terminal metabolism, SP and SP 6-11 were compared with cAMP-mediated activities in NK1R-expressing 3T3 fibroblasts. SP inhibits nuclear factor κB (NF-κB) activity, cell proliferation, and wound healing and stimulates collagen production. SP 6-11 had little or no activity. Cyclooxygenase-2 (COX-2) expression is increased by SP but not by SP 6-11. Thus, metabolism may select the cellular response to SP by inhibiting or redirecting the second messenger signaling pathway activated by the NK1R.NEW & NOTEWORTHY Endothelial cells, macrophages, and fibroblasts metabolize substance P (SP) to N- and C-terminal metabolites with SP 5-11 as the most abundant metabolite. SP activates neurokinin-1 receptors to increase intracellular calcium and cyclic AMP. In contrast, SP metabolites of N-terminal metabolism and C-terminal deamidation retain the ability to increase calcium but lose the ability to increase cyclic AMP. These new insights indicate that the metabolism of SP directs cellular functions by regulating specific signaling pathways.

Negative Feedback on the Effects of Stem Cell Factor on Hematopoiesis is Partly Mediated Through Neutral Endopeptidase Activity on Substance P: a Combined Functional and Proteomic Study

Effects Of Sp(1-4) On Cobblestone-Forming Cells. Implications For Endopeptidases As Hematopoietic Regulators

The Dynamics of Bone Marrow Stromal Cells in the Proliferation of Multipotent Hematopoietic Progenitors by Substance P: an Understanding of the Effects of a Neurotransmitter on the Differentiating Hematopoietic Stem Cell.

Effects of Preprotachykinin‐I Peptides on Hematopoietic Homeostasis: A Role for Bone Marrow Endopeptidases

Mimicry Between Neurokinin-1 and Fibronectin May Explain the Transport and Stability of Increased Substance P Immunoreactivity in Patients with Bone Marrow Fibrosis

Induction of Hypoxia-Inducible Factor-1Alpha and Activation of Caspase-3 in Hypoxia-Reoxygenated Bone Marrow Stroma is Negatively Regulated by the Delayed Production of Substance P.

Crosstalk Between Neurokinin Receptors is Relevant to Hematopoietic Regulation: Cloning and Characterization of Neurokinin-2 Promoter

Hematopoietic growth factor inducible neurokinin-1 type: a transmembrane protein that is similar to neurokinin 1 interacts with substance P

Differences in the Expression of Neurokinin Receptor in Neural and Bone Marrow Mesenchymal Cells: Implications for Neuronal Expansion from Bone Marrow Cells

Substance P enhances mesenchymal stem cells-mediated immune modulation

Neuroimmune/Hematopoietic Axis with Distinct Regulation by the High-Mobility Group Box 1 in Association with Tachykinin Peptides.

Effects and mechanisms of substance P on the proliferation and angiogenic differentiation of bone marrow mesenchymal stem cells: Bioinformatics and in vitro experiments

Effect Of Substance P On Differentiation Of Bone Marrow Stromal Stem Cells Under Oxidative Stress

Stimulatory effects of neopterin on hematopoiesis in vitro are mediated by activation of stromal cell function

Cellular metabolism of substance P produces neurokinin-1 receptor peptide agonists with diminished cyclic AMP signaling

Substance P Induces Monocyte Chemoattractant Protein-1 Production In Skin Fibroblasts From Genetically-Diabetic Mice Via Activation Of Nf-Kappa B

The Synergy Between Stem Cell Factor (SCF) and Granulocyte Colony-stimulating Factor (G-CSF): Molecular Basis and Clinical Relevance

Effects of SDF-1 α and Its Receptor on Regulation of Hematopoiesis

Effects of recombinant human stem cell factor (SCF) on the growth of human progenitor cells in vitro

Effects of Sensory Neuropeptide Substance P on Cellular Proliferation of Granulation Tissue Fibroblast and Gene Expression of Epidermal Growth Factor Mrna

Effects of Prostaglandin E2 Receptor 4 Agonist on the Expression of Stem Factors in Human CD34+ Cells